AVENIO ctDNA Surveillance Kit V2

Overview

The AVENIO ctDNA Surveillance Kit is a next-generation sequencing (NGS) liquid biopsy research assay that’s specially designed and optimized for longitudinal tumor burden monitoring in lung cancer and colorectal cancer (CRC) research. The Surveillance panel contains 197 genes, including those in U.S. National Comprehensive Cancer Network (NCCN) Guidelines.¹

Features and Benefits
 

• Includes genes in the U.S. National Comprehensive Cancer Network (NCCN) Guidelines¹
• All four mutation classes (SNVs, indels, fusions and CNVs) in a single assay
• Exceptional analytical performance supported by integrated digital error suppression (iDES) strategies combining molecular barcodes with in silico error suppression techniques^2,3
• Includes reagents, bioinformatics and software
• Streamlined, end-to-end research workflow from extraction to analysis and reporting in five days
  

Exceptional Performance³

The AVENIO ctDNA Surveillance Kit V2 is one of three assays in the AVENIO ctDNA research assay portfolio. Learn more about the 17-gene AVENIO ctDNA Targeted Kit V2 for guideline-driven tumor profiling or the 77-gene AVENIO ctDNA Expanded Kit V2 for profiling emerging and guideline-driven biomarkers.